GO
Loading...

Pfizer Inc

More

  • *Results from Netflix expected after the market close. NEW YORK, April 21- U.S. stocks rose slightly on Monday as investors found few reasons to push indexes sharply higher following a strong rally last week and ahead of key earnings releases.

  • US STOCKS-Wall St flat as investors await earnings Monday, 21 Apr 2014 | 10:51 AM ET

    *Results from Netflix expected after the market close. NEW YORK, April 21- U.S. stocks were flat on Monday ahead of key earnings releases as investors found few reasons to push indexes sharply higher following a strong rally last week. The S&P 500 posted its best week since July last week, boosted by results from such names as General Electric Co and Morgan Stanley.

  • Early Glance: Pharmaceuticals companies Monday, 21 Apr 2014 | 10:31 AM ET

    Baxter International Inc. rose$. 19 or. 3 percent, to $73.00. Bristol-Myers Squibb Co. rose$. 64 or 1.3 percent, to $50.10. Hospira rose$. 09 or. 2 percent, to $42.93.

  • Pfizer weighs massive bid for rival AstraZeneca Sunday, 20 Apr 2014 | 10:16 AM ET

    U.S. pharmaceutical giant Pfizer has approached British rival AstraZeneca to propose a 60 billion pound takeover, Britain's Sunday Times reported.

  • April 18- Biogen Idec Inc is pricing its newly approved long-acting hemophilia drug, Alprolix, to cost U.S. patients, and insurers, about the same per year as older, less convenient therapies whose price can reach about $300,000 annually.

  • April 17- Teva Pharmaceutical Industries Ltd signed a deal that allows the Israeli drugmaker to launch a generic version of Pfizer Inc's blockbuster painkiller Celebrex in December. "helps them to get through 2014 with a lot less competition," Morningstar analyst Damien Conover said.

  • Midday movers: Weibo, Sabre, Goldman Sachs & More Thursday, 17 Apr 2014 | 12:30 PM ET
    Sign for Sabre IPO on Nasdaq board

    Some of Thursday's midday movers:

  • April 17- Teva Pharmaceutical Industries Ltd said it settled a patent lawsuit with Pfizer Inc, allowing the Israeli drugmaker to launch a generic version of Pfizer's blockbuster painkiller Celebrex in December.

  • April 17- Teva Pharmaceutical Industries Ltd said it settled a patent litigation with Pfizer Inc, allowing the Israeli drugmaker to launch a generic version of Pfizer's blockbuster pain medication, Celebrex, in December. Celebrex's basic chemical patent expires on May 30.

  • Final Glance: Pharmaceuticals companies Wednesday, 16 Apr 2014 | 6:02 PM ET

    Baxter International Inc. rose$. 09 or. 1 percent, to $73.45. Bristol-Myers Squibb Co. rose$. 94 or 2.0 percent, to $49.11. Hospira fell$. 43 or 1.0 percent, to $43.00.

  • Midday Glance: Pharmaceuticals companies Wednesday, 16 Apr 2014 | 1:30 PM ET

    Baxter International Inc. fell$. 04 or. 1 percent, to $73.32. Bristol-Myers Squibb Co. rose $1.00 or 2.1 percent, to $49.17. Hospira fell$. 52 or 1.2 percent, to $42.91.

  • Most active New York Stock Exchange-traded stocks Wednesday, 16 Apr 2014 | 1:30 PM ET

    NEW YORK— A look at New York Stock Exchange 10 most-active stocks at the close of trading:. AT&T Inc. rose 1.2 percent to $36.10 with 23,832,000 shares traded. Alcoa Inc. rose 2.8 percent to $13.42 with 36,770,000 shares traded.

  • Early Glance: Pharmaceuticals companies Wednesday, 16 Apr 2014 | 10:27 AM ET

    Baxter International Inc. rose$. 51 or. 7 percent, to $73.87. Bristol-Myers Squibb Co. rose$. 40 or. 8 percent, to $48.57. Hospira fell$. 24 or. 6 percent, to $43.19.

  • Final Glance: Pharmaceuticals companies Monday, 14 Apr 2014 | 6:01 PM ET

    Baxter International Inc. rose$. 78 or 1.1 percent, to $72.76. Bristol-Myers Squibb Co. fell$. 87 or 1.8 percent, to $47.96. Hospira rose$. 79 or 1.9 percent, to $42.93.

  • Most active New York Stock Exchange-traded stocks Monday, 14 Apr 2014 | 2:08 PM ET

    NEW YORK— A look at New York Stock Exchange 10 most-active stocks at the close of trading:. Advanced Micro Devices Inc. rose 1.6 percent to $3.71 with 22,506,600 shares traded. Alcoa Inc. rose 2.6 percent to $12.86 with 29,500,100 shares traded.

  • Midday Glance: Pharmaceuticals companies Monday, 14 Apr 2014 | 2:08 PM ET

    Baxter International Inc. rose$. 79 or 1.1 percent, to $72.77. Bristol-Myers Squibb Co. fell$. 39 or. 8 percent, to $48.44. Hospira rose $1.35 or 3.2 percent, to $43.49.

  • Early Glance: Pharmaceuticals companies Monday, 14 Apr 2014 | 10:21 AM ET

    Baxter International Inc. rose$. 47 or. 7 percent, to $72.45. Bristol-Myers Squibb Co. fell$. 07 or. 1 percent, to $48.77. Hospira rose$. 10 or. 2 percent, to $42.24.

  • Final Glance: Pharmaceuticals companies Friday, 11 Apr 2014 | 6:03 PM ET

    Baxter International Inc. fell$. 28 or. 4 percent, to $71.98. Bristol-Myers Squibb Co. fell$. 46 or. 9 percent, to $48.83. Hospira fell$. 58 or 1.4 percent, to $42.14.

  • Midday Glance: Pharmaceuticals companies Friday, 11 Apr 2014 | 1:51 PM ET

    Baxter International Inc. rose$. 15 or. 2 percent, to $72.41. Bristol-Myers Squibb Co. rose$. 07 or. 1 percent, to $49.36. Hospira fell$. 26 or. 6 percent, to $42.46.

  • Most active New York Stock Exchange-traded stocks Friday, 11 Apr 2014 | 1:51 PM ET

    NEW YORK— A look at New York Stock Exchange 10 most-active stocks at the close of trading:. AT&T Inc. rose. 2 percent to $35.20 with 34,303,500 shares traded. Alcoa Inc. fell 1.3 percent to $12.54 with 44,879,300 shares traded.

Most Popular Video

Monday, 21 Apr 2014 | 9:21 AM ET

Art Cashin, UBS director of floor operations, discusses earnings season and what he's watching ahead of the market open.

Monday, 21 Apr 2014 | 8:37 AM ET

Fred Davis, Arista Advisors CEO, discusses his plans to finance tech startups in Silicon Valley.

Monday, 21 Apr 2014 | 8:33 AM ET

CNBC's Scott Cohn talks with Boston Mayor Martin Walsh about the security challenges surrounding this year's marathon.